JPH072698B2 - Amide derivative and external preparation for skin containing the same - Google Patents

Amide derivative and external preparation for skin containing the same

Info

Publication number
JPH072698B2
JPH072698B2 JP12646289A JP12646289A JPH072698B2 JP H072698 B2 JPH072698 B2 JP H072698B2 JP 12646289 A JP12646289 A JP 12646289A JP 12646289 A JP12646289 A JP 12646289A JP H072698 B2 JPH072698 B2 JP H072698B2
Authority
JP
Japan
Prior art keywords
skin
amide derivative
mmol
external preparation
reaction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP12646289A
Other languages
Japanese (ja)
Other versions
JPH02306952A (en
Inventor
幸浩 大橋
真司 矢野
章 川俣
峰広 奥田
玄爾 芋川
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kao Corp
Original Assignee
Kao Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kao Corp filed Critical Kao Corp
Priority to JP12646289A priority Critical patent/JPH072698B2/en
Priority to ES90109167T priority patent/ES2058670T3/en
Priority to DE69011402T priority patent/DE69011402T2/en
Priority to AT90109167T priority patent/ATE109767T1/en
Priority to EP90109167A priority patent/EP0398272B1/en
Priority to US07/524,864 priority patent/US5175321A/en
Publication of JPH02306952A publication Critical patent/JPH02306952A/en
Priority to US07/794,980 priority patent/US5221757A/en
Publication of JPH072698B2 publication Critical patent/JPH072698B2/en
Priority to HK116296A priority patent/HK116296A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Description

【発明の詳細な説明】 〔産業上の利用分野〕 本発明は、新規なアミド誘導体、及びそれを含有する皮
膚外用剤、特に、角層のバリアー機能を本質的に改善
(正常なバリアー機能の維持、障害を受けたバリアー機
能の回復)し得る皮膚外用剤に関する。
The present invention relates to a novel amide derivative, and a skin external preparation containing the same, and in particular, the barrier function of the stratum corneum is essentially improved (of normal barrier function). The present invention relates to a skin external preparation capable of maintaining and recovering a damaged barrier function).

〔従来の技術〕[Conventional technology]

角層は、皮膚の最表面にあって、体表面全体を覆い、体
外からの刺激や異物の侵入を防ぎ、また体内からの水分
の蒸散を防ぐ等の役割を果たしている。
The stratum corneum is located on the outermost surface of the skin and covers the entire body surface, plays a role of preventing irritation from the outside of the body and invasion of foreign substances, and preventing evaporation of water from the body.

しかし、何らかの原因によって角層のバリアー機能が弱
まると、皮膚に炎症が起きやすくなったり、肌あれが生
じ易くなるなどの問題が起こる。
However, if the barrier function of the stratum corneum is weakened for some reason, problems such as easy inflammation of the skin and easy occurrence of rough skin occur.

また、アラキドン酸やリノール酸などの必須脂肪酸を含
まない食物を摂取し続けるなどして体内で必須脂肪酸が
不足もしくは欠乏し、必須脂肪酸欠乏症になると、角層
のバリアー機能に障害が生じることが知られている。
It is also known that when essential fatty acids are deficient or deficient in the body by continuing to eat foods that do not contain essential fatty acids such as arachidonic acid and linoleic acid, and essential fatty acid deficiency occurs, the barrier function of the stratum corneum is impaired. Has been.

そして、上記角層のバリアー機能の維持には、角層細胞
間の脂質、特にO−アシルセラミドが極めて重要な働き
を示すことが、細胞間の脂質の分析等の結果から明らか
となっている。
It has been clarified from the results of analysis of intercellular lipids that lipids between corneal cells, particularly O-acylceramide, play an extremely important role in maintaining the barrier function of the corneal layer. .

また、皮脂腺から分泌される脂質が皮表で皮脂膜を形成
することにより、角層のバリアー機能の一部が補われる
とされており、従来、ワセリン等を配合した皮膚外用剤
等が、皮膚表面に被膜を形成させて角層のバリアー機能
を補充する目的で使用されている。
In addition, it is said that a part of the barrier function of the stratum corneum is supplemented by the lipid secreted from the sebaceous glands forming the sebaceous membrane on the skin surface. Conventionally, skin external preparations containing vaseline etc. It is used for the purpose of forming a film on the surface and supplementing the barrier function of the stratum corneum.

〔発明が解決しようとする課題〕[Problems to be Solved by the Invention]

しかしながら、従来の皮膚外用剤等は、あくまでも一時
的に皮膚表面に被膜を形成させてバリアー機能を補充し
ているにすぎず、本質的に角層のバリアー機能を改善さ
せるものではなかった。
However, conventional external preparations for skin and the like merely form a film on the skin surface temporarily to replenish the barrier function, and do not essentially improve the barrier function of the stratum corneum.

従って、本発明の目的は、角層の正常なバリアー機能を
維持することができ、また障害を受けたバリアー機能を
回復することのできる皮膚外用剤、即ち、角層のバリア
ー機能を本質的に改善でき、炎症や肌あれ等を起こし難
くする皮膚外用剤を提供することにある。
Therefore, the object of the present invention is to maintain the normal barrier function of the stratum corneum and to restore the damaged barrier function, that is, the external barrier agent of the stratum corneum. It is intended to provide an external preparation for the skin which can be improved and which makes it less likely to cause inflammation, rough skin and the like.

〔課題を解決するための手段〕[Means for Solving the Problems]

本発明者らは、上記目的を達成すべく鋭意研究した結
果、下記一般式(I)で表される新規アミド誘導体を含
有する皮膚外用剤が角層のバリアー機能を本質的に改善
できることを見出し、本発明を完成した。
As a result of earnest studies to achieve the above-mentioned object, the present inventors have found that an external preparation for skin containing a novel amide derivative represented by the following general formula (I) can essentially improve the barrier function of the stratum corneum. The present invention has been completed.

(式中、R1は炭素数10〜40の直鎖若しくは分岐鎖の飽和
若しくは不飽和の炭化水素基を示し、R2は炭素数3〜39
の直鎖若しくは分岐鎖の炭化水素基を示し、R3は水素原
子又は炭素数10〜40の直鎖若しくは分岐鎖の飽和若しく
は不飽和の炭化水素基若しくはアシル基を示す。) 即ち、本発明は、前記一般式(I)で表わされるアミド
誘導体及びそれを含有する皮膚外用剤を提供するもので
ある。
(In the formula, R 1 represents a linear or branched saturated or unsaturated hydrocarbon group having 10 to 40 carbon atoms, and R 2 represents 3 to 39 carbon atoms.
Is a straight chain or branched chain hydrocarbon group, and R 3 is a hydrogen atom or a straight chain or branched chain saturated or unsaturated hydrocarbon group having 10 to 40 carbon atoms or an acyl group. That is, the present invention provides an amide derivative represented by the general formula (I) and a skin external preparation containing the amide derivative.

以下、まず本発明のアミド誘導体について説明する。Hereinafter, the amide derivative of the present invention will be described first.

前記一般式(I)で表わされる本発明のアミド誘導体
は、その製造法は特に限定されるものではなく、例え
ば、次の(1)〜(3)の方法により製造することがで
きる。
The production method of the amide derivative of the present invention represented by the general formula (I) is not particularly limited, and can be produced, for example, by the following methods (1) to (3).

(1)前記一般式(I)においてR3が水素原子であるア
ミド誘導体(I−A)の製造方法: 上記アミド誘導体(I−A)は、公知の方法〔例えば、
特開昭63-216852号公報に記載の方法〕に準じて製造す
ることができる。即ち、次に示される反応式に従ってグ
リシジルエーテルとエタノールアミンから得られるアミ
ン誘導体(II)に対して、塩基触媒の存在下でヒドロキ
シ脂肪酸低級アルキルエステル(III-A)又はヒドロキ
シ脂肪酸ラクトン(IV)を作用させ、生成する低級アル
コールを留去しつつ反応させることにより製造すること
ができる。
(1) Method for producing an amide derivative (IA) in which R 3 is a hydrogen atom in the general formula (I): The amide derivative (IA) is a known method [for example,
The method described in JP-A-63-216852]. That is, a hydroxy fatty acid lower alkyl ester (III-A) or hydroxy fatty acid lactone (IV) was added to an amine derivative (II) obtained from glycidyl ether and ethanolamine according to the reaction formula shown below in the presence of a base catalyst. It can be produced by causing the reaction to occur while distilling off the produced lower alcohol.

(式中、R1及びR2は前記一般式(I)における場合と同
じ意味を表わし、R4は炭素数1〜5のアルキル基を示
す。) (2)前記一般式(I)においてR3が炭素数10〜40の直
鎖若しくは分岐鎖の飽和若しくは不飽和の炭化水素基で
あるアミド誘導体(I−B)の製造方法: 上記アミド誘導体(I−B)は、次に示される反応式に
従って、ヒドロキシ脂肪酸(III)若しくはヒドロキシ
脂肪酸エステル(III-A)とアルキルハライド(V)若
しくはスルホン酸アルキルエステル(VI)とを塩基の存
在下で反応させることによりエーテル化脂肪酸エステル
(III-B)を得、これと前記(1)の方法で得られるア
ミン誘導体(II)とを塩基触媒存在下で作用させ、生成
するアルコールを留去しつつ反応させることにより、製
造することができる。
(In the formula, R 1 and R 2 have the same meanings as in the case of the general formula (I), and R 4 represents an alkyl group having 1 to 5 carbon atoms.) (2) In the general formula (I), R 4 Method for producing amide derivative (IB) in which 3 is a linear or branched saturated or unsaturated hydrocarbon group having 10 to 40 carbon atoms: The above amide derivative (IB) is a reaction shown by the following. According to the formula, an etherified fatty acid ester (III-B) is obtained by reacting a hydroxy fatty acid (III) or hydroxy fatty acid ester (III-A) with an alkyl halide (V) or a sulfonic acid alkyl ester (VI) in the presence of a base. ) Is obtained, and this is reacted with the amine derivative (II) obtained by the above method (1) in the presence of a base catalyst, and the produced alcohol is reacted while distilling off.

(式中、R1、R2及びR4は前記(1)の反応式における場
合と同じ意味を表わし、R3は炭素数10〜40の直鎖若しく
は分岐鎖の飽和若しくは不飽和の炭化水素基を示し、R5
はメチル基、フェニル基又はp−トルイル基を示す。ま
た、XはCl、Br又はIを示す。) (3)前記一般式(I)においてR3が炭素数10〜40の直
鎖若しくは分岐鎖の飽和若しくは不飽和のアシル基であ
るアミド誘導体(I−C)の製造方法: 上記アミド誘導体(I−C)は、次に示される反応式に
従って、ヒドロキシ脂肪酸エステル(III-A)と脂肪酸
(VII)とを適当な脱水剤〔例えば、 及びP(C6H5)3〕の存在下に縮合させてアシル脂肪酸エ
ステル(III-C)とし、これと前記(1)の方法で得ら
れるアミン誘導体(II)とを塩基触媒存在下で作用さ
せ、生成するアルコールを留去しつつ反応させることに
より、製造することができる。
(In the formula, R 1 , R 2 and R 4 have the same meanings as in the reaction formula (1), and R 3 is a straight or branched chain saturated or unsaturated hydrocarbon having 10 to 40 carbon atoms. Represents a group, R 5
Represents a methyl group, a phenyl group or a p-toluyl group. X represents Cl, Br or I. (3) A method for producing an amide derivative (IC) in which R 3 in the general formula (I) is a linear or branched saturated or unsaturated acyl group having 10 to 40 carbon atoms: I-C) is prepared by reacting a hydroxy fatty acid ester (III-A) and a fatty acid (VII) with a suitable dehydrating agent [eg, according to the reaction formula shown below. And P (C 6 H 5 ) 3 ] in the presence of an acyl fatty acid ester (III-C), and the amine derivative (II) obtained by the method (1) above in the presence of a base catalyst. It can be produced by reacting it while allowing it to act and distill off the produced alcohol.

(式中、R1、R2及びR4は前記(1)の反応式における場
合と同じ意味を表わし、R6は炭素数9〜39の直鎖若しく
は分岐鎖の飽和若しくは不飽和の炭化水素基を示す。) また、上記アミド誘導体(I−C)は、適当な保護基を
用いて次に示される反応式に従っても製造することがで
きる。
(In the formula, R 1 , R 2 and R 4 have the same meaning as in the reaction formula of the above (1), and R 6 is a linear or branched saturated or unsaturated hydrocarbon having 9 to 39 carbon atoms. Further, the above amide derivative (IC) can also be produced according to the reaction formula shown below using an appropriate protecting group.

(式中、R1、R2、R4及びR6は、前記の反応式における場
合と同じ意味を表わし、R7は基 又は を示し、R8はアセチル基又はtert−ブチルジフェニルシ
リル基を示す。) 即ち、ヒドロキシ脂肪酸エステル(III-A)のヒドロキ
シ基をテトラヒドロピラニル基、エトキシエチル基等の
エーテル系保護基R7で保護した後、アミン誘導体(II)
と塩基触媒存在下で反応させ、アミド誘導体(IX)と
し、次いで、アミド誘導体(IX)の2つのヒドロキシ基
をアセチル基又はtert−ブチルジフェニルシリル基
(R8)で保護した後、保護基R7を、酸触媒存在下にアル
コールを作用させて脱保護して、アミド誘導体(XI)と
し、次いで、適当な脱水剤〔例えば、 及びP(C6H5)3〕の存在下に脂肪酸(VII)を作用させる
か、又は塩基の存在下に脂肪酸クロリド(XII)を作用
させて、アミド誘導体(XIII)とし、最後に、保護基R8
を脱保護〔R8がアセチル基の場合、低級アルコール中K2
CO3、Na2CO3等の塩基を用い、また、R8がtert−ブチル
ジフェニルシリル基の場合、フッ化テトラブチルアンモ
ニウム等のフッ素イオンを用いる〕して、アミド誘導体
(I−C)得る。
(In the formula, R 1 , R 2 , R 4 and R 6 have the same meanings as in the above reaction formula, and R 7 is a group. Or And R 8 represents an acetyl group or a tert-butyldiphenylsilyl group. ) That is, after protecting the hydroxy group of the hydroxy fatty acid ester (III-A) with an ether protecting group R 7 such as tetrahydropyranyl group and ethoxyethyl group, the amine derivative (II)
With a base catalyst to give an amide derivative (IX), and then two hydroxy groups of the amide derivative (IX) are protected with an acetyl group or a tert-butyldiphenylsilyl group (R 8 ), followed by a protecting group R 7 is deprotected by reacting alcohol with an alcohol in the presence of an acid catalyst to give an amide derivative (XI), and then a suitable dehydrating agent [eg, And P (C 6 H 5 ) 3 ] in the presence of a fatty acid (VII) or in the presence of a base, a fatty acid chloride (XII) to act as an amide derivative (XIII), and finally, protection. Group R 8
Deprotection [when R 8 is an acetyl group, K 2 in a lower alcohol
With CO 3, Na 2 CO 3 or the like of the base, and when R 8 is tert- butyldiphenylsilyl group, using a fluoride ion such as tetrabutylammonium fluoride] to give the amide derivative (I-C) .

次に、上述の本発明のアミド誘導体を含有する本発明の
皮膚外用剤について説明する。
Next, the external preparation for skin of the present invention containing the above-mentioned amide derivative of the present invention will be described.

本発明のアミド誘導体を本発明の皮膚外用剤として用い
る場合の配合量は、特に制限されないが、通常、乳化型
の皮膚外用剤の場合には全組成の0.001〜50重量%(以
下、単に%で示す)が好ましく、スクワラン等の液状炭
化水素を基剤とする油性の皮膚外用剤の場合には0.01〜
50%が好ましい。
The amount of the amide derivative of the present invention used when used as the external preparation for skin of the present invention is not particularly limited, but in the case of an emulsion type external preparation for skin, 0.001 to 50% by weight of the total composition (hereinafter, simply referred to as% In the case of oily external preparation for skin based on liquid hydrocarbon such as squalane, 0.01 to
50% is preferred.

本発明の皮膚外用剤は、従来の皮膚外用剤の基剤に前記
一般式(I)で表されるアミド誘導体を含有させてなる
もので、その使用形態において、薬用皮膚外用剤と化粧
料に大別される。
The skin external preparation of the present invention comprises a conventional skin external preparation base and an amide derivative represented by the general formula (I). Broadly divided.

薬用皮膚外用剤としては、例えば、薬効成分を含有する
各種軟膏剤を挙げることができる。軟膏剤としては、油
性基剤をベースとするもの、油/水、水/油型の乳化系
基剤をベースとするもののいずれであってもよい。上記
油性基剤としては、特に制限はなく、例えば、植物油、
動物油、合成油、脂肪酸、及び天然又は合成のグリセラ
イド等が挙げられる。また、上記薬効成分としては、特
に制限はなく、例えば、鎮痛消炎剤、鎮痒剤、殺菌消毒
剤、収斂剤、皮膚軟化剤、ホルモン剤等を必要に応じて
適宜使用することができる。
Examples of the external medicated skin agent include various ointments containing medicinal components. The ointment may be either an oil-based base, an oil / water, or a water / oil-type emulsion base. The oily base is not particularly limited, for example, vegetable oil,
Examples thereof include animal oils, synthetic oils, fatty acids, and natural or synthetic glycerides. In addition, the medicinal component is not particularly limited, and for example, an analgesic / anti-inflammatory agent, an antipruritic agent, a bactericidal / antiseptic agent, an astringent agent, an emollient agent, a hormone agent and the like can be appropriately used as necessary.

また、化粧料として使用する場合は、必須成分である本
発明のアミド誘導体の他に、化粧料成分として一般に使
用されている油分、保湿剤、紫外線吸収剤、アルコール
類、キレート剤、pH調整剤、防腐剤、増粘剤、色素、香
料等を任意に組み合わせて配合することができる。
When used as a cosmetic, in addition to the amide derivative of the present invention which is an essential component, oils, moisturizers, UV absorbers, alcohols, chelating agents, pH adjusters that are commonly used as cosmetic ingredients. , An antiseptic, a thickener, a dye, a fragrance and the like can be arbitrarily combined and blended.

化粧料としては、種々の形態、例えば、水/油、油/水
型乳化化粧料、クリーム、化粧乳液、化粧水、油性化粧
料、口紅、ファンデーション、皮膚洗浄剤、ヘアートニ
ック、整髪剤、養毛剤、育毛剤等の皮膚化粧料とするこ
とができる。
As cosmetics, various forms, for example, water / oil, oil / water emulsion cosmetics, creams, lotions, lotions, oily cosmetics, lipsticks, foundations, skin cleansers, hairnics, hairdressing agents, hair nourishing agents , And a skin cosmetic such as a hair restorer.

〔作用〕[Action]

前記一般式(I)で表される本発明のアミド誘導体を含
有する皮膚外用剤の作用機構の詳細は完全には解明され
ていないが、皮膚外用剤として皮膚に適用されることに
より、角質細胞間の脂質膜を補強して角層のバリアー機
能を改善するものと推察される。
Although the details of the mechanism of action of the external preparation for skin containing the amide derivative of the present invention represented by the general formula (I) has not been completely elucidated, keratinocytes can be obtained by applying it to the skin as an external preparation for skin. It is presumed that it strengthens the intervening lipid membrane and improves the barrier function of the stratum corneum.

〔実施例〕〔Example〕

次に、実施例を挙げて本発明を更に詳しく説明する。 Next, the present invention will be described in more detail with reference to examples.

実施例1 N−(2−ヒドロキシ−3−ヘキサデシロキシプロピ
ル)−N−2−ヒドロキシエチル−12−ヒドロキシオク
タデカンアミド〔前記一般式(I)においてR1=C16H33
-及び であるアミド誘導体〕(I-Aa)の合成: N−(2−ヒドロキシ−3−ヘキサデシロキシプロピ
ル)エタノールアミン(IIa)の合成: 攪拌装置、滴下漏斗、温度計及び還流冷却器を備えた20
0ml4ツ口フラスコにエタノールアミン61.1g(1.0mol)
を入れ、60〜70℃に加熱攪拌しつつ、これにヘキサデシ
ルグリシジルエーテル24.3g(0.082mol)を45分かけて
滴下した。滴下終了後、更に同条件下で2時間加熱攪拌
し、未反応のエタノールアミンを減圧下に留去(79〜81
℃/20Torr)した。残渣をシリカゲルフラッシュカラム
クロマトグラフィーで精製することにより、標記化合物
(IIa)18.4gを得た(収率63%)。尚、得られた化合物
1H-NMRの測定結果は次の通りであった。1 H-NMR(δ,CDCl3): 0.85(t,3H)、1.23(bs,28H)、2.6〜2.8(m,4H)、3.
1〜3.9(m,10H) アミド誘導体(I-Aa)の合成: 攪拌装置、滴下ロート、温度計及び蒸溜装置を備えた10
0mlフラスコに、上記で得た化合物(IIa)17.3g(48m
mol)及びKOH0.14g(2.5mmol)を仕込み、80℃/20Torr
で減圧下に加熱攪拌しつつ、12−ヒドロキシオクタデカ
ン酸メチル15.1g(48mmol)を1時間かけて滴下した。
滴下終了後、更に同条件下で1時間攪拌し、得られた粗
生成物をシリカゲルフラッシュカラムクロマトグラフィ
ーで精製することにより、標記化合物(I-Aa)23.0gを
得た(収率74%)。得られた化合物の融点、1R及び1H-N
MRの測定結果は次の通りであった。
Example 1 N- (2-hydroxy-3-hexadecyloxypropyl) -N-2-hydroxyethyl-12-hydroxyoctadecane amide [in the general formula (I), R 1 = C 16 H 33
-as well as Of amide derivative] (I-Aa): Synthesis of N- (2-hydroxy-3-hexadecyloxypropyl) ethanolamine (IIa): Stirrer, dropping funnel, thermometer and reflux condenser 20
61.1 g (1.0 mol) of ethanolamine in a 0 ml 4-necked flask
Was added, and while heating and stirring at 60 to 70 ° C., 24.3 g (0.082 mol) of hexadecyl glycidyl ether was added dropwise to this over 45 minutes. After completion of dropping, the mixture was further heated and stirred under the same conditions for 2 hours, and unreacted ethanolamine was distilled off under reduced pressure (79 to 81
C / 20 Torr). The residue was purified by silica gel flash column chromatography to obtain 18.4 g of the title compound (IIa) (yield 63%). The 1 H-NMR measurement results of the obtained compound are as follows. 1 H-NMR (δ, CDCl 3 ): 0.85 (t, 3H), 1.23 (bs, 28H), 2.6 to 2.8 (m, 4H), 3.
1 ~ 3.9 (m, 10H) Synthesis of amide derivative (I-Aa): 10 equipped with stirrer, dropping funnel, thermometer and distiller
In a 0 ml flask, 17.3 g (48 m) of the compound (IIa) obtained above
mol) and KOH 0.14 g (2.5 mmol) were charged, and 80 ℃ / 20Torr
While heating and stirring under reduced pressure at 15.1, 15.2 g (48 mmol) of methyl 12-hydroxyoctadecanoate was added dropwise over 1 hour.
After completion of the dropwise addition, the mixture was further stirred for 1 hour under the same conditions, and the obtained crude product was purified by silica gel flash column chromatography to obtain 23.0 g of the title compound (I-Aa) (yield 74%). . The melting point of the obtained compound, 1R and 1 HN
The MR measurement results were as follows.

融点:70.8〜71.3℃ IR:3352、2926、2854、1617、1473、1122、1077cm-1 1 H-NMR(δ,CDCl3): 0.88(t,J=6.3Hz,6H)、1.12〜1.82(m,56H)、2.24〜
2.51(m,2H)、3.23〜4.30(m,15H) 実施例2 N−(2−ヒドロキシ−3−ヘキサデシロキシプロピ
ル)−N−2−ヒドロキシエチル−16−ヒドロキシヘキ
サデカンアミド〔前記一般式(I)においてR1=C
16H33、R3OR2=HO(CH2)15-であるアミド誘導体〕(I-A
b)の合成: 実施例1ので得たアミン(IIa)と16−ヒドロキシヘ
キサデカン酸メチルとを実施例1のと同様の方法で反
応させ、無色粉末の目的化合物(I-Ab)を得た(収率75
%)。得られた化合物の融点、IR及び1H-NMRの測定結果
は次の通りであった。
Mp: 70.8~71.3 ℃ IR: 3352,2926,2854,1617,1473,1122,1077cm -1 1 H-NMR (δ, CDCl 3): 0.88 (t, J = 6.3Hz, 6H), 1.12~1.82 ( m, 56H), 2.24 ~
2.51 (m, 2H), 3.23 to 4.30 (m, 15H) Example 2 N- (2-hydroxy-3-hexadecyloxypropyl) -N-2-hydroxyethyl-16-hydroxyhexadecanamide [the above general formula ( In I) R 1 = C
16 H 33 , R 3 OR 2 = HO (CH 2 ) 15 -is an amide derivative] (IA
Synthesis of b): The amine (IIa) obtained in Example 1 was reacted with methyl 16-hydroxyhexadecanoate in the same manner as in Example 1 to obtain the target compound (I-Ab) as a colorless powder ( Yield 75
%). The melting point, IR and 1 H-NMR measurement results of the obtained compound are as follows.

融点:80.6〜81.5℃ IR:3370、2920、2854、1626、1596、1473、1131、106
2、723cm-1 1 H-NMR(δ,CDCl3): 0.88(t,J=6.6Hz,3H)、0.96〜1.80(m,54H)、2.30〜
2.48(m,2H)、3.24〜4.17(m,15H) 実施例3 N−(2−ヒドロキシ−3−ヘキサデシロキシプロピ
ル)−N−2−ヒドロキシエチル−16−(9Z,12Z−オク
タデカジエニロキシ)ヘキサデカンアミド〔前記一般式
(I)においてR1=C16H33及び であるアミド誘導体〕(I-Ba)の合成: 16−(9Z,12Z−オクタデカジエニロキシ)ヘキサデカ
ン酸メチル(III-Ba)の合成: 攪拌装置、滴下ロート、温度計及び還流冷却器を備えた
300ml4ツ口フラスコに、16−ヒドロキシヘキサデカン酸
2.72g(10mmol)、無水テトラヒドロフラン50ml、無水
ヘキサメチルホスホリルトリアミド5ml及び水素化ナト
リウム0.24g(10mmol)を入れ、N2気流下、室温で30分
間攪拌した。次いで、この混合物を−70℃まで冷却し、
1.6Nブチルリチウムヘキサン溶液6.25ml(10mmol)を加
えた後、30分かけて室温まで加温し、ここで水素化ナト
リウム0.24g(10mmol)を加えてさらに30分間室温で攪
拌した。次に、ここにp−トルエンスルホン酸9Z,12Z−
オクタデカジエニルエステル9.25g(22mmol)を滴下
し、65℃で18時間加熱攪拌し、次いでこの反応混合物に
無水メタノール150mlを加え、更に65℃で1時間攪拌し
た。反応混合物を室温まで冷却後、塩化アンモニウム水
溶液で過剰のアルカリを中和し、トルエンで反応混合物
を抽出し、溶媒を減圧留去後、残渣をフラッシュカラム
クロマトグラフィーで精製することにより、標記化合物
(III-Ba)0.72gを得た(収率13.5%)。
Melting point: 80.6-81.5 ° C IR: 3370, 2920, 2854, 1626, 1596, 1473, 1131, 106
2,723cm -1 1 H-NMR (δ , CDCl 3): 0.88 (t, J = 6.6Hz, 3H), 0.96~1.80 (m, 54H), 2.30~
2.48 (m, 2H), 3.24-4.17 (m, 15H) Example 3 N- (2-hydroxy-3-hexadecyloxypropyl) -N-2-hydroxyethyl-16- (9Z, 12Z-octadecadi Enoxy) hexadecanamide [in the general formula (I), R 1 ═C 16 H 33 and Is an amide derivative] (I-Ba): Synthesis of methyl 16- (9Z, 12Z-octadecadienyloxy) hexadecanoate (III-Ba): Stirrer, dropping funnel, thermometer and reflux condenser Prepared
In a 300 ml 4-necked flask, 16-hydroxyhexadecanoic acid
2.72 g (10 mmol), anhydrous tetrahydrofuran 50 ml, anhydrous hexamethylphosphoryltriamide 5 ml and sodium hydride 0.24 g (10 mmol) were added, and the mixture was stirred at room temperature for 30 minutes under N 2 gas flow. The mixture was then cooled to -70 ° C,
After adding 6.25 ml (10 mmol) of 1.6N butyllithium hexane solution, the mixture was heated to room temperature over 30 minutes, 0.24 g (10 mmol) of sodium hydride was added thereto, and the mixture was further stirred at room temperature for 30 minutes. Next, p-toluenesulfonic acid 9Z, 12Z-
9.25 g (22 mmol) of octadecadienyl ester was added dropwise, and the mixture was heated and stirred at 65 ° C for 18 hours, 150 ml of anhydrous methanol was added to the reaction mixture, and the mixture was further stirred at 65 ° C for 1 hour. After cooling the reaction mixture to room temperature, excess alkali was neutralized with an aqueous solution of ammonium chloride, the reaction mixture was extracted with toluene, the solvent was evaporated under reduced pressure, and the residue was purified by flash column chromatography to give the title compound ( III-Ba) 0.72 g was obtained (yield 13.5%).

アミド誘導体(I-Ba)の合成: 上記で得た化合物(III-Ba)と実施例1ので得たア
ミン(IIa)とを実施例1のと同様の方法で反応さ
せ、無色粉末の目的化合物(I-Ba)を得た(収率71
%)。得られた化合物の融点、IR及び1H-NMRの測定結果
は次の通りであった。
Synthesis of amide derivative (I-Ba): The compound (III-Ba) obtained above and the amine (IIa) obtained in Example 1 were reacted in the same manner as in Example 1 to give the target compound as a colorless powder. (I-Ba) was obtained (yield 71
%). The melting point, IR and 1 H-NMR measurement results of the obtained compound are as follows.

融点:63.0〜64.3℃ IR:3304、2920、2854、1614、1467、1116、1062、720cm
-1 1 H-NMR(δ,CDCl3): 0.80〜0.95(m,6H)、0.95〜1.70(m,72H)、1.95〜2.1
2(m,4H)、2.39(t,J=7.7Hz,2H)、2.77(bt,J=5.7H
z,2H)、3.39(t,J=6.6Hz,4H)、3.23〜4.23(m,13
H)、5.24〜5.44(m,4H) 実施例4 N−(2−ヒドロキシ−3−ヘキサデシロキシプロピ
ル)−N−2−ヒドロキシエチル−16−(9Z,12Z−オク
タデカジエノイルオキシ)ヘキサデカンアミド〔前記一
般式(I)においてR1=C16H33-及び であるアミド誘導体〕(I-Ca)の合成: 16−(9Z,12Z−オクタデカジエノイルオキシ)ヘキサ
デカン酸メチル(III-Ca)の合成: 攪拌装置、滴下ロート及び温度計を備えた300mlフラス
コに、16−ヒドロキシヘキサデカン酸メチル4.30g(15m
mol)、リノール酸8.41g(13mmol)、トリフェニルホス
フィン7.87g(30mmol)及びテトラヒドロフラン100mlを
仕込み、室温で攪拌下にアゾジカルボン酸ジエチル5.22
g(30mmol)を1時間かけて滴下した。滴下終了後、更
に室温で4時間攪拌した後、溶媒を減圧下に留去し、残
渣をシリカゲルフラッシュクロマトグラフィーで精製す
ることにり、標記化合物(III-Ca)6.76gを得た(収率8
2%)。
Melting point: 63.0-64.3 ° C IR: 3304, 2920, 2854, 1614, 1467, 1116, 1062, 720cm
-1 1 H-NMR (δ, CDCl 3 ): 0.80 to 0.95 (m, 6H), 0.95 to 1.70 (m, 72H), 1.95 to 2.1
2 (m, 4H), 2.39 (t, J = 7.7Hz, 2H), 2.77 (bt, J = 5.7H
z, 2H), 3.39 (t, J = 6.6Hz, 4H), 3.23 to 4.23 (m, 13
H), 5.24 to 5.44 (m, 4H) Example 4 N- (2-hydroxy-3-hexadecyloxypropyl) -N-2-hydroxyethyl-16- (9Z, 12Z-octadecadienoyloxy) hexadecane Amide [in the general formula (I), R 1 = C 16 H 33 -and Synthesis of amide derivative] (I-Ca): Synthesis of methyl 16- (9Z, 12Z-octadecadienoyloxy) hexadecanoate (III-Ca): 300 ml flask equipped with stirrer, dropping funnel and thermometer In addition, 4.30 g of methyl 16-hydroxyhexadecanoate (15 m
mol), 8.41 g (13 mmol) of linoleic acid, 7.87 g (30 mmol) of triphenylphosphine and 100 ml of tetrahydrofuran, and diethyl azodicarboxylate 5.22 with stirring at room temperature.
g (30 mmol) was added dropwise over 1 hour. After completion of the dropwise addition, the mixture was further stirred at room temperature for 4 hours, the solvent was distilled off under reduced pressure, and the residue was purified by silica gel flash chromatography to obtain 6.76 g of the title compound (III-Ca) (yield 8
2%).

アミド誘導体(I-Ca)の合成: 攪拌装置、滴下ロート、温度計及び蒸溜装置を備えた50
mlフラスコに、上記で得た化合物(III-Ca)2.74g(5
mmol)、実施例1ので得たアミン(IIa)1.80g(5mmo
l)及びカリウムtert−ブトキシド0.028g(0.25mmol)
を仕込み、80℃/20Torrの減圧下で30分間加熱攪拌し
た。得られた粗生成物をシリカゲルカラムクロマトグラ
フィー及びゲルクロマトグラフィーで精製することによ
り、標記化合物(I-Ca)1.65gを得た(収率38%)。得
られた化合物の融点、IR、1H-NMR及びMSの測定結果は次
の通りであった。
Synthesis of amide derivative (I-Ca): 50 equipped with stirrer, dropping funnel, thermometer and distillation device
2.74 g (5%) of the compound (III-Ca) obtained above in a ml flask.
mmol), 1.80 g (5 mmo of amine (IIa) obtained in Example 1)
l) and potassium tert-butoxide 0.028 g (0.25 mmol)
Was charged, and the mixture was heated and stirred for 30 minutes under reduced pressure of 80 ° C./20 Torr. The obtained crude product was purified by silica gel column chromatography and gel chromatography to obtain 1.65 g of the title compound (I-Ca) (yield 38%). The measurement results of melting point, IR, 1 H-NMR and MS of the obtained compound were as follows.

融点:58.2〜58.9℃ IR:3304、2920、2856、1734、1612、1464、1440、121
6、1166、1108、756、720cm-1 1 H-NMR(δ,CDCl3): 0.80〜1.00(m,6H)、1.00〜1.73(m,70H)、1.95〜2.1
6(m,4H)、2.28(t,J=7.5Hz,2H)、2.39(bt,J=7.7H
z,2H)、2.77(bt,J=5.9Hz,2H)、3.23〜4.25(m,13
H)、4.05(t,J=6.6Hz,2H)、5.26〜5.47(m,4H) MS(FAB,POS): 877(M+1)、859、634、596、360 (FAB,NEG): 875(M−1)、873、831、613、534、359、305、279 実施例5 N−(2−ヒドロキシ−3−ヘキサデシロキシプロピ
ル)−N−2−ヒドロキシエチル−16−(9Z−オクタデ
セノイルオキシ)ヘキサデカンアミド〔前記一般式
(I)において、R1=C16H33-及び であるアミド誘導体〕(I-Cb)の合成: N−(2−ヒドロキシ−3−ヘキサデシロキシプロピ
ル)−N−2−ヒドロキシエチル−16−(2−テトラヒ
ドロピラニルオキシ)ヘキサデカンアミド(IX-b)の合
成: 撹拌装置及び滴下ロートを備えた1フラスコに、16−
ヒドロキシヘキサデカン酸メチル100.26g(0.35mol)、
p−トルエンスルホン酸0.60g(3.5mmol)及びジクロロ
メタン350mlを仕込み、0℃にて撹拌しながらジヒドロ
ピラン32.39g(0.385mol)を滴下した。滴下終了後、1
時間室温で撹拌して反応を完結させた。次いで、反応混
合物にNaHCO30.59g(7mmol)を加えて中和し、濾過、溶
媒留去して、16−(2−テトラヒドロピラニルオキシ)
ヘキサデカン酸メチル粗製物を得た。
Melting point: 58.2-58.9 ° C IR: 3304, 2920, 2856, 1734, 1612, 1464, 1440, 121
6,1166,1108,756,720cm -1 1 H-NMR (δ , CDCl 3): 0.80~1.00 (m, 6H), 1.00~1.73 (m, 70H), 1.95~2.1
6 (m, 4H), 2.28 (t, J = 7.5Hz, 2H), 2.39 (bt, J = 7.7H
z, 2H), 2.77 (bt, J = 5.9Hz, 2H), 3.23-4.25 (m, 13
H), 4.05 (t, J = 6.6Hz, 2H), 5.26 to 5.47 (m, 4H) MS (FAB, POS): 877 (M + 1), 859, 634, 596, 360 (FAB, NEG): 875 ( M-1), 873, 831, 613, 534, 359, 305, 279 Example 5 N- (2-hydroxy-3-hexadecyloxypropyl) -N-2-hydroxyethyl-16- (9Z-octade Cenoyloxy) hexadecanamide [in the general formula (I), R 1 ═C 16 H 33 − and Is an amide derivative] (I-Cb): N- (2-hydroxy-3-hexadecyloxypropyl) -N-2-hydroxyethyl-16- (2-tetrahydropyranyloxy) hexadecanamide (IX- Synthesis of b): In one flask equipped with a stirrer and a dropping funnel, 16-
Methyl hydroxyhexadecanoate 100.26g (0.35mol),
0.60 g (3.5 mmol) of p-toluenesulfonic acid and 350 ml of dichloromethane were charged, and 32.39 g (0.385 mol) of dihydropyran was added dropwise with stirring at 0 ° C. After completion of dropping, 1
The reaction was completed by stirring at room temperature for hours. Next, 0.59 g (7 mmol) of NaHCO 3 was added to the reaction mixture for neutralization, filtration and evaporation of the solvent to give 16- (2-tetrahydropyranyloxy).
A crude product of methyl hexadecanoate was obtained.

次に、撹拌装置、滴下ロート、温度計及び蒸留装置を備
えた1フラスコに、実施例1ので得られたN−(2
−ヒドロキシ−3−ヘキサデシロキシプロピル)エタノ
ールアミン(IIa)125.9g(0.35mol)及びKOH0.98g(1
7.5mmol)を仕込み、80℃/20Torrの減圧下に加熱撹拌し
つつ、上記で得た16−(2−テトラヒドロピラニルオキ
シ)ヘキサデカン酸メチル粗製物を2時間かけて滴下
し、生成してくるメタノールを留去した。滴下終了後、
更に同条件下で2時間撹拌し、得られた粗生成物をメタ
ノールより再結晶することにより、化合物(IX-b)212.
3gを得た(収率86.9%)。
Next, in one flask equipped with a stirrer, a dropping funnel, a thermometer and a distillation device, the N- (2 obtained in Example 1 was obtained.
-Hydroxy-3-hexadecyloxypropyl) ethanolamine (IIa) 125.9 g (0.35 mol) and KOH 0.98 g (1
(7.5 mmol) was charged, and the methyl 16- (2-tetrahydropyranyloxy) hexadecanoate crude product obtained above was added dropwise over 2 hours while stirring under heating at 80 ° C./20 Torr under reduced pressure to generate. The methanol was distilled off. After the dropping is completed,
The mixture was further stirred under the same conditions for 2 hours, and the obtained crude product was recrystallized from methanol to give compound (IX-b) 212.
3 g was obtained (yield 86.9%).

N−(2−(tert−ブチルジフェニルシリルオキシ)
−3−ヘキサデシロキシプロピル)−N−2−(tert−
ブチルジフェニルシリルオキシ)エチル−16−ヒドロキ
シヘキサデカンアミド(XI-b)の合成: 撹拌装置及び滴下ロートを備えた1フラスコに、上記
で得た化合物(IX-b)34.91g(0.05mol)、イミダゾ
ール13.62g(0.2mol)及びジメチルホルムアミド350ml
を仕込み、室温で撹拌しながらtert−ブチルジフェニル
クロロシラン30.24g(0.11mol)を滴下し、50℃に加温
して14時間撹拌した。反応終了後、反応混合物をジエチ
ルエーテルで抽出し、食塩水で洗浄後、溶媒を減圧留去
した。
N- (2- (tert-butyldiphenylsilyloxy)
-3-Hexadecyloxypropyl) -N-2- (tert-
Synthesis of butyldiphenylsilyloxy) ethyl-16-hydroxyhexadecanamide (XI-b): In one flask equipped with a stirrer and a dropping funnel, 34.91 g (0.05 mol) of compound (IX-b) obtained above, imidazole 13.62g (0.2mol) and dimethylformamide 350ml
Was charged, 30.24 g (0.11 mol) of tert-butyldiphenylchlorosilane was added dropwise with stirring at room temperature, and the mixture was heated to 50 ° C. and stirred for 14 hours. After completion of the reaction, the reaction mixture was extracted with diethyl ether, washed with brine, and the solvent was evaporated under reduced pressure.

次に、上記で得られた残渣を撹拌装置を備えた1フラ
スコに仕込み、ここにエタノール550ml、メタノール150
ml及びパラトルエンスルンホン酸ピリジニウム2.36g
(9.4mmol)を加え、室温で28時間撹拌した。反応終了
後、NaHCO3で中和し、ジエチルエーテルで反応混合物を
抽出し、溶媒を減圧留去後、残渣をシリカゲルフラッシ
ュカラムクロマトグラフィーで精製することにより、化
合物(XI-b)39.5gを得た(収率72.4%)。
Next, the residue obtained above was charged into one flask equipped with a stirrer, and 550 ml of ethanol and 150 ml of methanol were charged therein.
ml and pyridinium paratoluene sulphonate 2.36 g
(9.4 mmol) was added, and the mixture was stirred at room temperature for 28 hours. After the reaction was completed, the reaction mixture was neutralized with NaHCO 3 , the reaction mixture was extracted with diethyl ether, the solvent was distilled off under reduced pressure, and the residue was purified by silica gel flash column chromatography to obtain 39.5 g of compound (XI-b). (Yield 72.4%).

アミド誘導体(I-Cb)の合成: 撹拌装置及び滴下ロートを備えた200mlフラスコに、上
記で得た化合物(XI-b)4.25g(3.9mmol)、ピリジン
1.23g(15.6mmol)及びジクロロメタン50mlを仕込み、
室温で撹拌しながら塩化オレオイル1.41g(4.7mmol)を
滴下した。滴下終了後さらに1時間室温で撹拌して反応
を完結させ、反応混合物を水で洗浄し、溶媒を減圧留去
後、シリカゲルショートカラムクロマトグラフィーで高
極性副生成物を除去し、粗生成物を得た。
Synthesis of amide derivative (I-Cb): In a 200 ml flask equipped with a stirrer and a dropping funnel, 4.25 g (3.9 mmol) of compound (XI-b) obtained above, pyridine
Charge 1.23 g (15.6 mmol) and 50 ml of dichloromethane,
1.41 g (4.7 mmol) of oleoyl chloride was added dropwise with stirring at room temperature. After completion of the dropwise addition, the reaction was completed by stirring at room temperature for 1 hour, the reaction mixture was washed with water, the solvent was distilled off under reduced pressure, and the highly polar by-product was removed by silica gel short column chromatography to obtain a crude product. Obtained.

次に、上記で得られた粗生成物を撹拌装置を備えた200m
lフラスコに仕込み、ここにテトラヒドロフラン50ml及
びフッ化テトラブチルアンモニウム2.46g(7.8mmol)を
加え、室温で30分撹拌した。反応終了後、反応混合物を
クロロホルムで抽出し、食塩水で洗浄後、溶媒を減圧留
去し、残渣をシリカゲルフラッシュカラムクロマトグラ
フィーで精製することにより、標記化合物(I-Cb)2.67
gを得た(収率77.9%)。得られた化合物の融点、IR及
1H-NMRの測定結果は次の通りであった。
Next, the crude product obtained above was treated with a stirring device for 200 m.
Into a 1-flask, 50 ml of tetrahydrofuran and 2.46 g (7.8 mmol) of tetrabutylammonium fluoride were added, and the mixture was stirred at room temperature for 30 minutes. After completion of the reaction, the reaction mixture was extracted with chloroform, washed with brine, the solvent was evaporated under reduced pressure, and the residue was purified by silica gel flash column chromatography to give the title compound (I-Cb) 2.67.
g was obtained (yield 77.9%). The melting point, IR and 1 H-NMR measurement results of the obtained compound are as follows.

融点:60.4〜61.3℃ IR:3304、2920、2854、1737、1617、1467、1443、119
1、1110、1062、723cm-1 1 H-NMR(δ,CDCl3): 0.88(t,J=6.4Hz,6H)、1.10〜1.85(m,76H)、1.85〜
2.10(m,4H)、2.29(t,J=7.5Hz,2H)、2.39(bt,J=
7.6Hz,2H)、3.21〜4.20(m,13H)、4.05(t,J=6.7Hz,
2H)、5.34(bt,J=5.3Hz,2H) 実施例6 N−(2−ヒドロキシ−3−ヘキサデシロキシプロピ
ル)−N−2−ヒドロキシエチル−16−(メチルヘプデ
カノイルオキシ)ヘキサデカンアミド〔前記一般式
(I)において、R1=C16H33-及び (式中、pはp=7を頂点とする分布を有する整数を表
わす)であるアミド誘導体〕(I-Cc)の合成: 実施例5のにおいて、塩化オレオイルの代わりに塩化
メチルヘプタデカノイルを用いる以外は実施例5と同様
に反応を行って、目的化合物(I-Cc)を得た(収率65.5
%)。得られた化合物の融点、IR及び1H-NMRの測定結果
は次の通りであった。
Melting point: 60.4-61.3 ° C IR: 3304, 2920, 2854, 1737, 1617, 1467, 1443, 119
1,1110,1062,723cm -1 1 H-NMR (δ , CDCl 3): 0.88 (t, J = 6.4Hz, 6H), 1.10~1.85 (m, 76H), 1.85~
2.10 (m, 4H), 2.29 (t, J = 7.5Hz, 2H), 2.39 (bt, J =
7.6Hz, 2H), 3.21 ~ 4.20 (m, 13H), 4.05 (t, J = 6.7Hz,
2H), 5.34 (bt, J = 5.3Hz, 2H) Example 6 N- (2-hydroxy-3-hexadecyloxypropyl) -N-2-hydroxyethyl-16- (methylhepdecanoyloxy) hexadecanamide [In the general formula (I), R 1 = C 16 H 33 -and (Wherein p represents an integer having a distribution with p = 7 at the apex)] Synthesis of (I-Cc): Methylheptadecanoyl chloride in place of oleoyl chloride in Example 5. The reaction was performed in the same manner as in Example 5 except that was used to obtain the target compound (I-Cc) (yield: 65.5).
%). The melting point, IR and 1 H-NMR measurement results of the obtained compound are as follows.

融点:60.1〜62.0℃ IR:3298、2926、2380、1737、1614、1467、1443、120
3、1110、1059、720cm-1 1 H-NMR(δ,CDCl3): 0.77〜1.00(m,9H)、1.03〜1.75(m,81H)、2.29(t,J
=7.5Hz,2H)、2.40(bt,J=7.3Hz,2H)、3.24〜4.33
(m,13H)、4.05(t,J=6.6Hz,2H) 実施例7 N−(2−ヒドロキシ−3−ヘキサデシロキシプロピ
ル)−N−2−ヒドロキシエチル−32−(9Z,12Z−オク
タデカジエノイルオキシ)ドトリアコンタンアミド〔前
記一般式(I)において、R1=C16H33-及び であるアミド誘導体〕(I-Cd)の合成; 実施例5のにおいて、16−ヒドロキシヘキサデカン酸
メチルの代わりに32−ヒドロキシドトリアコンタン酸メ
チルを用い、且つ実施例5のにおいて、塩化オレオイ
ルの代わりに塩化リノレオイルを用いる以外は実施例5
と同様に反応を行って、目的化合物(I-Cd)を得た(収
率24.8%)。得られた化合物の融点、IR及び1H-NMRの測
定結果は次の通りであった。
Melting point: 60.1-62.0 ° C IR: 3298, 2926, 2380, 1737, 1614, 1467, 1443, 120
3,1110,1059,720cm -1 1 H-NMR (δ , CDCl 3): 0.77~1.00 (m, 9H), 1.03~1.75 (m, 81H), 2.29 (t, J
= 7.5Hz, 2H), 2.40 (bt, J = 7.3Hz, 2H), 3.24 to 4.33
(M, 13H), 4.05 (t, J = 6.6Hz, 2H) Example 7 N- (2-hydroxy-3-hexadecyloxypropyl) -N-2-hydroxyethyl-3- (9Z, 12Z-octa Decadienoyloxy) dotriacontanamide [in the general formula (I), R 1 ═C 16 H 33 − and Synthesis of amide derivative] (I-Cd) of Example 5; In Example 5, methyl 16-hydroxyhexadecanoate was replaced with methyl 32-hydroxydotriacontanate, and in Example 5, oleoyl chloride was added. Example 5 except that linoleoyl chloride was used instead
A target compound (I-Cd) was obtained by performing a reaction in the same manner as in (24.8% yield). The melting point, IR and 1 H-NMR measurement results of the obtained compound are as follows.

融点:72.4〜73.0℃ IR:3304、2920、2852、1738、1614、1466、1442、116
8、1112、1062、760、722cm-1 1 H-NMR(δ,CDCl3): 0.81〜1.01(m,6H)、1.10〜1.72(m,92H)、1.95〜2.1
5(m,4H)、2.29(t,J=7.5Hz,2H)、2.39(bt,J=7.6H
z,2H)、2.77(bt,J=5.7Hz,2H)、3.18〜4.20(m,13
H)、4.05(t,J=6.7Hz,2H)、5.23〜5.46(m,4H) 実施例8 N−(2−ヒドロキシ−3−ヘキサデシロキシプロピ
ル)−N−2−ヒドロキシエチル−16−(12−ヒドロキ
シオクタデカノイルオキシ)ヘキサデカンアミド〔前記
一般式(I)において、 R1=C16H33-及び であるアミド誘導体〕(I-Ce)の合成: 12−(tert−ブチルジメチルシリルオキシ)オクタデ
カン酸の合成; 撹拌装置及び滴下ロートを備えた100mlフラスコに、12
−ヒドロキシオクタデカン酸エチル3.28g(10mmol)、
イミダゾール1.36g(20mmol)及びジメチルホルムアミ
ド50mlを仕込み、室温で撹拌しながらtert−ブチルジメ
チルクロロシラン1.66g(11mmol)を滴下した。滴下終
了後、反応混合物を50℃で18時間撹拌し、反応を終了さ
せた。次いで、反応混合物をエーテルで抽出し、食塩水
で洗浄後、溶媒を減圧留去し、残渣をシリカゲルフラッ
シュクロマトグラフィーで精製して、12−(tert−ブチ
ルジメチルシリルオキシ)オクタデカン酸エチルを得
た。
Melting point: 72.4-73.0 ° C IR: 3304, 2920, 2852, 1738, 1614, 1466, 1442, 116
8,1112,1062,760,722cm -1 1 H-NMR (δ , CDCl 3): 0.81~1.01 (m, 6H), 1.10~1.72 (m, 92H), 1.95~2.1
5 (m, 4H), 2.29 (t, J = 7.5Hz, 2H), 2.39 (bt, J = 7.6H
z, 2H), 2.77 (bt, J = 5.7Hz, 2H), 3.18-4.20 (m, 13
H), 4.05 (t, J = 6.7 Hz, 2H), 5.23 to 5.46 (m, 4H) Example 8 N- (2-hydroxy-3-hexadecyloxypropyl) -N-2-hydroxyethyl-16- (12-Hydroxyoctadecanoyloxy) hexadecanamide [in the above general formula (I), R 1 = C 16 H 33 -and Synthesis of 12- (tert-butyldimethylsilyloxy) octadecanoic acid; In a 100 ml flask equipped with a stirrer and a dropping funnel, 12- (tert-butyldimethylsilyloxy) octadecanoic acid was added.
-Ethyl hydroxyoctadecanoate 3.28 g (10 mmol),
1.36 g (20 mmol) of imidazole and 50 ml of dimethylformamide were charged, and 1.66 g (11 mmol) of tert-butyldimethylchlorosilane was added dropwise while stirring at room temperature. After completion of the dropwise addition, the reaction mixture was stirred at 50 ° C. for 18 hours to terminate the reaction. Then, the reaction mixture was extracted with ether, washed with brine, the solvent was evaporated under reduced pressure, and the residue was purified by silica gel flash chromatography to obtain ethyl 12- (tert-butyldimethylsilyloxy) octadecanoate. .

次に、上記で得た12−(tert−ブチルジメチルシリルオ
キシ)オクタデカン酸エチルを撹拌装置を備えた100ml
のフラスコに仕込み、ここにエタノール20ml及び50%KO
H水溶液2.24g(20mmol)を加え、室温で4時間撹拌し
た。反応終了後、得られた反応混合物を塩酸で中和後、
クロロホルムで抽出し、溶媒を減圧留去して、12−(te
rt−ブチルジメチルシリルオキシ)オクタデカン酸4.0g
を得た(収率96.4%)。
Next, 100 ml of the ethyl 12- (tert-butyldimethylsilyloxy) octadecanoate obtained above was equipped with a stirrer.
Place in a flask and add 20 ml of ethanol and 50% KO here.
2.24 g (20 mmol) of H aqueous solution was added, and the mixture was stirred at room temperature for 4 hours. After the reaction was completed, the obtained reaction mixture was neutralized with hydrochloric acid,
Chloroform extracted, the solvent was distilled off under reduced pressure, and 12- (te
rt-Butyldimethylsilyloxy) octadecanoic acid 4.0 g
Was obtained (yield 96.4%).

アミド誘導体(I-Ce)の合成: 撹拌装置、滴下ロート及び温度計を備えた100mlフラス
コに、上記で得た12−(tert−ブチルジメチルシリル
オキシ)オクタデカン酸1.87g(4.5mmol)、実施例5の
で得た化合物(XI-b)3.27g(3mmol)、トリフェニル
ホスフィン1.18g(4.5mmol)及びテトラヒドロフラン10
mlを仕込み、室温で撹拌下にアゾジカルボン酸ジエチル
0.71g(4.05mmol)のテトラヒドロフラン5ml溶液を5分
間かけて滴下した。滴下終了後更に室温で4時間撹拌し
た後、溶媒を減圧下で留去し、残渣をシリカゲルフラッ
シュカラムクロマトグラフィーで精製した。
Synthesis of amide derivative (I-Ce): In a 100 ml flask equipped with a stirrer, a dropping funnel and a thermometer, 12.87 g (4.5 mmol) of 12- (tert-butyldimethylsilyloxy) octadecanoic acid obtained above, Example 5.27 g (3 mmol) of the compound (XI-b) obtained in 5 above, 1.18 g (4.5 mmol) of triphenylphosphine and 10
Charge ml and stir at room temperature with stirring with diethyl azodicarboxylate.
A solution of 0.71 g (4.05 mmol) in 5 ml of tetrahydrofuran was added dropwise over 5 minutes. After the dropwise addition was completed, the mixture was further stirred at room temperature for 4 hours, the solvent was distilled off under reduced pressure, and the residue was purified by silica gel flash column chromatography.

次に、上記で得られた中間体を撹拌装置を備えた100ml
フラスコに仕込み、ここにテトラヒドロフラン60ml及び
フッ化テトラブチルアンモニウム3.24g(10.3mmol)を
加え、60℃で24時間加熱撹拌した。次いで、得られた反
応混合物をクロロホルムで抽出し、食塩水で洗浄後、溶
媒を減圧留去し、残渣をシリカゲルフラッシュカラムク
ロマトグラフィーで精製することにより、標記化合物
(I-Ce)0.63gを得た(収率23.4%)。得られた化合物
の融点、IR及び1H-NMRの測定結果は次の通りであった。
Next, 100 ml of the intermediate obtained above was equipped with a stirrer.
The mixture was placed in a flask, tetrahydrofuran (60 ml) and tetrabutylammonium fluoride (3.24 g, 10.3 mmol) were added thereto, and the mixture was heated with stirring at 60 ° C for 24 hours. Then, the obtained reaction mixture was extracted with chloroform, washed with brine, the solvent was evaporated under reduced pressure, and the residue was purified by silica gel flash column chromatography to obtain 0.63 g of the title compound (I-Ce). (Yield 23.4%). The melting point, IR and 1 H-NMR measurement results of the obtained compound are as follows.

融点:71.7〜73.7℃ IR:3336、2920、2852、1740、1620、1470、1180、111
6、1060、722cm-1 1 H-NMR(δ,CDCl3): 0.89(bt,J=6.2Hz,6H)、1.07〜2.00(m,82H)、2.30
(t,J=7.5Hz,2H)、2.40(bt,J=7.6Hz,2H)、3.22〜
4.21(m,15H)、4.06(t,J=6.6Hz,2) 実施例9 N−(2−ヒドロキシ−3−ヘキサデシロキシプロピ
ル)−N−2−ヒドロキシエチル−16−(9,10,12−ト
リヒドロキシオクタデカノイルオキシ)ヘキサデカンア
ミド〔前記一般式(I)において、R1=C16H33-及び であるアミド誘導体〕(I-Cf)の合成: 実施例8のにおいて、12−ヒドロキシオクタデカン酸
エチルの代わりに9,10,12−トリヒドロキシオクタデカ
ン酸エチルを用いる以外は実施例8と同様に反応を行っ
て、目的化合物(I-Cf)を得た(収率32.7%)。得られ
た化合物の融点、IR及び1H-NMRの測定結果は次の通りで
あった。
Melting point: 71.7-73.7 ° C IR: 3336, 2920, 2852, 1740, 1620, 1470, 1180, 111
6,1060,722cm -1 1 H-NMR (δ , CDCl 3): 0.89 (bt, J = 6.2Hz, 6H), 1.07~2.00 (m, 82H), 2.30
(T, J = 7.5Hz, 2H), 2.40 (bt, J = 7.6Hz, 2H), 3.22 ~
4.21 (m, 15H), 4.06 (t, J = 6.6Hz, 2) Example 9 N- (2-hydroxy-3-hexadecyloxypropyl) -N-2-hydroxyethyl-16- (9,10, 12-trihydroxyoctadecanoyloxy) hexadecanamide [in the general formula (I), R 1 = C 16 H 33 -and Synthesis of amide derivative] (I-Cf): Reaction similar to that in Example 8 except that ethyl 9,10,12-trihydroxyoctadecanoate was used in place of ethyl 12-hydroxyoctadecanoate in Example 8. Was carried out to obtain the target compound (I-Cf) (yield 32.7%). The melting point, IR and 1 H-NMR measurement results of the obtained compound are as follows.

融点:75.8〜79.2℃ IR:3300、2924、2856、1728、1620、1470、1178、112
0、1070、722cm-1 1 H-NMR(δ,CDCl3): 0.82〜1.02(m,6H)、1.15〜2.30(m,78H)、2.30(t,J
=7.4Hz,2H)、2.41(bt,J=7.6Hz,2H)、3.22〜4.26
(m,19H)、4.07(t,J=6.6Hz,2H) 実施例10 N−(2−ヒドロキシ−3−ヘキサデシロキシプロピ
ル)−N−2−ヒドロキシエチル−12−(9Z,12Z−オク
タデカジエノイルオキシ)ドデカンアミド〔前記一般式
(I)において、R1=C16H33-及び であるアミド誘導体〕(I-Cg)の合成: N−(2−ヒドロキシ−3−ヘキサデシロキシプロピ
ル)−N−2−ヒドロキシエチル−12−(2−テトラヒ
ドロピラニルオキシ)ドデカンアミド(IX-g)の合成: 実施例5のにおいて、16−ヒドロキシヘキサデカン酸
メチルの代わりに12−ヒドロキシドデカン酸メチルを用
いた以外は実施例5のと同様にして目的化合物(IX-
g)を得た(収率67.8%)。
Melting point: 75.8-79.2 ° C IR: 3300, 2924, 2856, 1728, 1620, 1470, 1178, 112
0,1070,722cm -1 1 H-NMR (δ , CDCl 3): 0.82~1.02 (m, 6H), 1.15~2.30 (m, 78H), 2.30 (t, J
= 7.4Hz, 2H), 2.41 (bt, J = 7.6Hz, 2H), 3.22 to 4.26
(M, 19H), 4.07 (t, J = 6.6Hz, 2H) Example 10 N- (2-hydroxy-3-hexadecyloxypropyl) -N-2-hydroxyethyl-12- (9Z, 12Z-octa Decadienoyloxy) dodecanamide [in the general formula (I), R 1 ═C 16 H 33 − and Of amide derivative] (I-Cg): N- (2-hydroxy-3-hexadecyloxypropyl) -N-2-hydroxyethyl-12- (2-tetrahydropyranyloxy) dodecane amide (IX- Synthesis of g): In the same manner as in Example 5 except that methyl 12-hydroxydodecanoate was used in place of methyl 16-hydroxyhexadecanoate in Example 5, the target compound (IX-
g) was obtained (yield 67.8%).

N−(2−アセトキシ−3−ヘキサデシロキシプロピ
ル)−N−2−アセトキシエチル−12−ヒドロキシドデ
カンアミド(XI-g)の合成: 撹拌装置及び滴下ロートを備えた1フラスコに、上記
で得た化合物(IX-g)167.0g(0.23mol)、ピリジン9
1.0g(1.15mol)及びジクロロメタン440mlを仕込み、0
℃で撹拌下に塩化アセチル45.1g(0.575mol)を1.5時間
かけて滴下した。滴下終了後、更に1時間反応を行い、
反応を完結させた。次いで、この反応混合物にメタノー
ル7.4g(0.23mol)を加えて過剰の塩化アセチルを反応
させ、得られた混合物を、水、2N−塩酸及び食塩水で洗
浄し、溶媒を留去した。
Synthesis of N- (2-acetoxy-3-hexadecyloxypropyl) -N-2-acetoxyethyl-12-hydroxydodecanamide (XI-g): Obtained as above in one flask equipped with stirrer and dropping funnel. Compound (IX-g) 167.0g (0.23mol), pyridine 9
Charge 1.0 g (1.15 mol) and 440 ml of dichloromethane,
45.1 g (0.575 mol) of acetyl chloride was added dropwise over 1.5 hours with stirring at ℃. After the dropping is completed, the reaction is further performed for 1 hour,
The reaction was completed. Then, 7.4 g (0.23 mol) of methanol was added to this reaction mixture to react with excess acetyl chloride, and the obtained mixture was washed with water, 2N-hydrochloric acid and brine, and the solvent was evaporated.

次に、上記で得られた中間体を撹拌装置を備えた1フ
ラスコに仕込み、ここにメタノール368g(0.115mol)及
びパラトルエンスルホン酸ピリジニウム1.16g(4.6mmo
l)を加えて40℃で5時間撹拌した。反応終了後、NaHCO
30.76g(9.2mmol)を加えて中和し、メタノールを留去
後、残渣をクロロホルムに溶解させ、食塩水で洗浄し、
溶媒を減圧留去し、残渣をシリカゲルショートカラムク
ロマトグラフィーで精製して、目的化合物(XI-g)118.
3gを得た(収率80.1%)。
Next, the intermediate obtained above was charged into one flask equipped with a stirrer, and 368 g (0.115 mol) of methanol and 1.16 g (4.6 mmo of pyridinium paratoluenesulfonate were added thereto.
l) was added and the mixture was stirred at 40 ° C. for 5 hours. After completion of the reaction, NaHCO
3 0.76 g (9.2 mmol) was added for neutralization, methanol was distilled off, the residue was dissolved in chloroform and washed with brine,
The solvent was distilled off under reduced pressure, the residue was purified by silica gel short column chromatography, and the target compound (XI-g) 118.
3 g was obtained (yield 80.1%).

アミド誘導体(I-Cg)の合成: 撹拌装置及び滴下ロートを備えた1フラスコに、上記
で得た化合物(XI-g)73.6g(0.115mol)、ジクロロ
メタン160ml及びピリジン21.8g(0.276mol)を仕込み、
0℃で撹拌下に塩化リノレオイル41.2g(0.138mol)を3
0分かけて滴下し、滴下終了後更に2時間撹拌した。次
にここにメタノール1.6g(0.05mol)を加えて過剰の塩
化リノレオイルをリノール酸メチルとした後、反応混合
物を食塩水で洗浄し、溶媒を減圧留去し、残渣をシリカ
ゲルショートカラムクロマトグラフィーで精製した。
Synthesis of amide derivative (I-Cg): 73.6 g (0.115 mol) of the compound (XI-g) obtained above, 160 ml of dichloromethane and 21.8 g (0.276 mol) of pyridine were placed in a flask equipped with a stirrer and a dropping funnel. Preparation,
41.2 g (0.138 mol) of linoleoyl chloride was mixed with stirring at 0 ° C.
The solution was added dropwise over 0 minutes, and after the completion of the addition, stirring was continued for 2 hours. Next, 1.6 g (0.05 mol) of methanol was added to this to make excess linoleoyl chloride into methyl linoleate, the reaction mixture was washed with brine, the solvent was distilled off under reduced pressure, and the residue was subjected to silica gel short column chromatography. Purified.

次に、上記で得た中間体を撹拌装置を備えた3lフラスコ
に仕込み、ここにエタノール1、メタノール0.5l及び
K2CO329.4g(0.213mol)を加えて0〜10℃で1時間撹拌
した。反応終了後、水を加えて生成している塩を溶解さ
せ、ジイソプロピルエーテルで反応混合物を抽出し、食
塩水で洗浄し、溶媒を減圧留去後、残渣をシリカゲルフ
ラッシュカラムクロマトグラフィーで精製することによ
り、標記化合物(I-Cg)62.0gを得た(収率65.7%)。
得られた化合物の融点、IR及び1H-NMRの測定結果は次の
通りであった。
Next, the intermediate obtained above was charged into a 3 l flask equipped with a stirrer, and ethanol 1, methanol 0.5 l and
29.4 g (0.213 mol) of K 2 CO 3 was added, and the mixture was stirred at 0 to 10 ° C for 1 hour. After the reaction is complete, add water to dissolve the formed salt, extract the reaction mixture with diisopropyl ether, wash with brine, evaporate the solvent under reduced pressure, and purify the residue by silica gel flash column chromatography. This gave 62.0 g of the title compound (I-Cg) (yield 65.7%).
The melting point, IR and 1 H-NMR measurement results of the obtained compound are as follows.

融点:50.6〜52.8℃ IR:3304、2924、2856、1734、1616、1470、1176、110
8、1060、720cm-1 1 H-NMR(δ,CDCl3): 0.82〜0.95(m,6H)、1.13〜1.74(m,62H)、1.96〜2.1
3(m,4H)、2.29(t,J=7.5Hz,2H)、2.39(bt,J=7.6H
z,2H)、2.77(bt,J=5.7Hz,2H)、3.22〜4.21(m,13
H)、4.05(t,J=6.71Hz,2H)、5.23〜5.48(m,4H) 実施例11 N−(2−ヒドロキシ−3−ヘキサデシロキシプロピ
ル)−N−2−ヒドロキシエチル−15−(9Z,12Z−オク
タデカジエノイルオキシ)ペンタデカンアミド〔前記一
般式(I)において、R1=C16H33-及び であるアミド誘導体〕(I-Ch)の合成: 実施例10のにおいて、12−ヒドロキシドデカン酸メチ
ルの代わりに15−ヒドロキシペンタデカン酸メチルを用
いた以外は実施例10と同様に反応を行って、目的化合物
(I-Ch)を得た(収率42.3%)。得られた化合物の融
点、IR及び1H-NMRの測定結果は次の通りであった。
Melting point: 50.6-52.8 ° C IR: 3304, 2924, 2856, 1734, 1616, 1470, 1176, 110
8,1060,720cm -1 1 H-NMR (δ , CDCl 3): 0.82~0.95 (m, 6H), 1.13~1.74 (m, 62H), 1.96~2.1
3 (m, 4H), 2.29 (t, J = 7.5Hz, 2H), 2.39 (bt, J = 7.6H
z, 2H), 2.77 (bt, J = 5.7Hz, 2H), 3.22 to 4.21 (m, 13
H), 4.05 (t, J = 6.71 Hz, 2H), 5.23 to 5.48 (m, 4H) Example 11 N- (2-hydroxy-3-hexadecyloxypropyl) -N-2-hydroxyethyl-15- (9Z, 12Z-octadecadienoyloxy) pentadecanamide [in the above general formula (I), R 1 = C 16 H 33 -and Synthesis of amide derivative of (I-Ch): In Example 10, except that methyl 15-hydroxypentadecanoate was used instead of methyl 12-hydroxydodecanoate, a reaction was carried out in the same manner as in Example 10, The target compound (I-Ch) was obtained (yield 42.3%). The melting point, IR and 1 H-NMR measurement results of the obtained compound are as follows.

融点:64.2〜65.7℃ IR:3312、2924、2856、1734、1618、1466、1440、118
6、1110、1060、722cm-1 1 H-NMR(δ,CDCl3): 0.82〜0.97(m,6H)、1.15〜1.63(m,58H)、1.96〜2.1
4(m,4H)、2.29(t,J=7.5Hz,2H)、2.39(bt,J=7.6H
z,2H)、2.77(bt,J=5.7Hz,2H)、3.21〜4.20(m,13
H)、4.05(t,J=6.7Hz,2H)、5.23〜5.48(m,4H) 実施例12 下記第1表に示す本発明のアミド誘導体10%及びスクワ
ラン90%からなる本発明の皮膚外用剤をそれぞれ製造
し、これらの皮膚外用剤について、下記の試験方法によ
り経表皮水分蒸散量及び経皮吸収量を評価した。また、
比較としてスクワランのみからなる皮膚外用剤(比較
品)についても同様の試験を行った。その結果を下記第
1表に示す。
Melting point: 64.2-65.7 ° C IR: 3312, 2924, 2856, 1734, 1618, 1466, 1440, 118
6,1110,1060,722cm -1 1 H-NMR (δ , CDCl 3): 0.82~0.97 (m, 6H), 1.15~1.63 (m, 58H), 1.96~2.1
4 (m, 4H), 2.29 (t, J = 7.5Hz, 2H), 2.39 (bt, J = 7.6H
z, 2H), 2.77 (bt, J = 5.7Hz, 2H), 3.21 ~ 4.20 (m, 13
H), 4.05 (t, J = 6.7 Hz, 2H), 5.23 to 5.48 (m, 4H) Example 12 External use for the skin of the present invention consisting of 10% of the amide derivative of the present invention shown in Table 1 below and 90% of squalane. Each of these preparations was manufactured, and the transepidermal water loss and percutaneous absorption of these external preparations for skin were evaluated by the following test methods. Also,
As a comparison, the same test was performed on a skin external preparation (comparative product) consisting of squalane alone. The results are shown in Table 1 below.

(試験方法) 必須脂肪酸を含まない飼料のみでウィスター(Wister)
系雄性ラットを飼育し、必須脂肪酸欠乏症の症状が現れ
たラットに対し、剃毛した背部皮膚に皮膚外用剤を1日
1回3週間塗布する。3週間の塗布が終了した翌日に次
の項目について試験を行った。
(Test method) Wister with only feed that does not contain essential fatty acids
Male male rats are bred, and the external skin preparation is applied to the shaved back skin once a day for 3 weeks to the rats showing symptoms of essential fatty acid deficiency. The test was conducted on the following items the day after the application for 3 weeks was completed.

尚、皮膚外用剤それぞれについてラット3匹ずつを試験
に供した。
In addition, three rats were subjected to the test for each external preparation for skin.

(1)経表皮水分蒸散量 37℃の温水でラットの背部皮膚を洗浄後、温度20℃及び
湿度45%の部屋で1時間安静な状態においた後、表皮か
らの水分蒸散量をエバポリメーターにて測定した。この
水分蒸散量の値が大きいほど角層のバリアー機能が低下
しており、肌あれが生じていることを示す。
(1) Transepidermal water loss After washing the rat's back skin with warm water at 37 ℃, leave it in a room at a temperature of 20 ℃ and a humidity of 45% for 1 hour, and then measure the water loss from the epidermis with an evaporation meter. It was measured at. The larger the value of this water evaporation amount, the lower the barrier function of the stratum corneum, indicating that the skin is roughened.

正常なバリアー機能が維持されている場合、この値は10
以下となるが、バリアー機能が障害を受けた必須脂肪酸
欠乏症のラットでは35以上となる。測定値は平均値±標
準偏差で示した。
This value is 10 if the normal barrier function is maintained.
Below, but above 35 in essential fatty acid deficient rats with impaired barrier function. The measured values are shown as the average value ± standard deviation.

(2)経皮吸収量 37℃の温水でラットの背部皮膚を洗浄後、該皮膚を切り
取り、経皮吸収チャンバーに表皮側を上にしてはさみ込
む。下部受器にはリン酸緩衝平衡塩類溶液を満たし、表
皮側容器には37KBqの14C−サリチル酸を含む溶剤1mlを
入れる。2時間後に下部受器中に浸透した14C−サリチ
ル酸量を測定する。正常なバリアー機能が維持されてい
る場合、2時間ではほとんど浸透せず、バリアー機能の
障害が大きいほどこの値は大きくなる。測定値は平均値
±標準偏差で示した。
(2) Percutaneous absorption amount After washing the back skin of rats with warm water at 37 ° C, the skin is cut off and inserted into the transdermal absorption chamber with the epidermis side facing up. The lower receiver is filled with phosphate buffered balanced salt solution and the epidermal side container is filled with 1 ml of a solvent containing 37 KBq of 14 C-salicylic acid. After 2 hours, the amount of 14 C-salicylic acid that has penetrated into the lower receiver is measured. When the normal barrier function is maintained, it hardly penetrates in 2 hours, and the larger the impaired barrier function, the larger the value. The measured values are shown as the average value ± standard deviation.

実施例13 本発明のアミド誘導体を用いて、下記第2表に示す組成
の本発明の皮膚外用剤(乳化化粧料)をそれぞれ製造
し、その肌あれ改善効果を下記の試験方法により評価し
た。また、比較として本発明のアミド誘導体を含まない
皮膚外用剤(比較品)についても同様の試験を行った。
その結果を下記第3表に示す。
Example 13 Using the amide derivative of the present invention, a skin external preparation (emulsified cosmetic) of the present invention having the composition shown in Table 2 below was produced, and its skin roughening improving effect was evaluated by the following test methods. Further, for comparison, the same test was performed on an external preparation for skin (comparative product) containing no amide derivative of the present invention.
The results are shown in Table 3 below.

(試験方法) 冬期に頬部に肌あれを起こしている20〜40才の女性10名
を被験者とし、左右の頬に異なる皮膚外用剤を1日1回
3週間塗布する。3週間の塗布が終了した翌日に次の項
目について試験を行った。
(Test method) Ten females aged 20 to 40 who have rough skin on the cheeks in winter are used as test subjects, and different topical skin preparations are applied to the left and right cheeks once a day for 3 weeks. The test was conducted on the following items the day after the application for 3 weeks was completed.

(1)経表皮水分蒸散量 37℃の温水で洗顔後、温度20℃及び湿度45%の部屋で30
分間安静にした後、表皮からの水分蒸散量をエバポリメ
ーターにて測定した。この水分蒸散量の値が大きいほど
角層のバリアー機能が低下しており、肌あれが生じてい
ることを示す。この値が40を超えるとひどい肌あれであ
り、肌あれがほとんど認められない場合は10以下とな
る。測定値は平均値±標準偏差で示した。
(1) Transepidermal water loss 30 After washing the face with warm water at 37 ° C, 30 in a room at a temperature of 20 ° C and a humidity of 45%.
After resting for a minute, the amount of water evaporated from the epidermis was measured with an evaporation meter. The larger the value of this water evaporation amount, the lower the barrier function of the stratum corneum, indicating that the skin is roughened. When this value exceeds 40, the skin is severely roughened, and when it is hardly observed, it becomes 10 or less. The measured values are shown as the average value ± standard deviation.

(2)肌あれスコア 肌あれを肉眼で観察し、下記基準により判定した。スコ
アは平均値±標準偏差で示した。
(2) Skin roughness score The skin roughness was visually observed and judged according to the following criteria. The score was shown by the average value +/- standard deviation.

スコア 肌あれ判定 0 肌あれを認めない 1 かすかに肌あれを認める 2 肌あれを認める 3 ややひどい肌あれを認める 4 ひどい肌あれを認める 〔発明の効果〕 本発明のアミド誘導体を含有する皮膚外用剤は、角層の
バリアー機能を本質的に改善できる効果を有するもの
で、皮膚に適用することにより、炎症や肌あれ等を起こ
し難くすることができる。
Score Rough skin judgment 0 No rough skin is recognized 1 Slight rough skin is recognized 2 Rough skin is recognized 3 Slightly rough skin is recognized 4 Severe rough skin is recognized [Effects of the Invention] The external preparation for skin containing the amide derivative of the present invention has the effect of essentially improving the barrier function of the stratum corneum, and when applied to the skin, it is less likely to cause inflammation, rough skin, etc. can do.

Claims (2)

【特許請求の範囲】[Claims] 【請求項1】下記一般式(I)で表されるアミド誘導
体。 (式中、R1は炭素数10〜40の直鎖若しくは分岐鎖の飽和
若しくは不飽和の炭化水素基を示し、R2は炭素数3〜39
の直鎖若しくは分岐鎖の炭化水素基を示し、R3は水素原
子又は炭素数10〜40の直鎖若しくは分岐鎖の飽和若しく
は不飽和の炭化水素基若しくはアシル基を示す。)
1. An amide derivative represented by the following general formula (I). (In the formula, R 1 represents a linear or branched saturated or unsaturated hydrocarbon group having 10 to 40 carbon atoms, and R 2 represents 3 to 39 carbon atoms.
Is a straight chain or branched chain hydrocarbon group, and R 3 is a hydrogen atom or a straight chain or branched chain saturated or unsaturated hydrocarbon group having 10 to 40 carbon atoms or an acyl group. )
【請求項2】下記一般式(I)で表わされるアミド誘導
体を含有する皮膚外用剤。 (式中、R1は炭素数10〜40の直鎖若しくは分岐鎖の飽和
若しくは不飽和の炭化水素基を示し、R2は炭素数3〜39
の直鎖若しくは分岐鎖の炭化水素基を示し、R3は水素原
子又は炭素数10〜40の直鎖若しくは分岐鎖の飽和若しく
は不飽和の炭化水素基若しくはアシル基を示す。)
2. A skin external preparation containing an amide derivative represented by the following general formula (I). (In the formula, R 1 represents a linear or branched saturated or unsaturated hydrocarbon group having 10 to 40 carbon atoms, and R 2 represents 3 to 39 carbon atoms.
Is a straight chain or branched chain hydrocarbon group, and R 3 is a hydrogen atom or a straight chain or branched chain saturated or unsaturated hydrocarbon group having 10 to 40 carbon atoms or an acyl group. )
JP12646289A 1989-05-19 1989-05-19 Amide derivative and external preparation for skin containing the same Expired - Lifetime JPH072698B2 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
JP12646289A JPH072698B2 (en) 1989-05-19 1989-05-19 Amide derivative and external preparation for skin containing the same
ES90109167T ES2058670T3 (en) 1989-05-19 1990-05-15 AMIDIC DERIVATIVES AND DERMATOLOGICAL PREPARATIONS THAT CONTAIN THEM.
DE69011402T DE69011402T2 (en) 1989-05-19 1990-05-15 Amide derivatives and skin preparations containing them.
AT90109167T ATE109767T1 (en) 1989-05-19 1990-05-15 AMIDE DERIVATIVES AND SKIN PREPARATIONS CONTAINING THEM.
EP90109167A EP0398272B1 (en) 1989-05-19 1990-05-15 Amide derivatives and dermatologic preparations containing the same
US07/524,864 US5175321A (en) 1989-05-19 1990-05-18 Amide derivatives and dermatologic preparations containing the same
US07/794,980 US5221757A (en) 1989-05-19 1991-11-20 Amide derivatives and dermatologic preparations containing the same
HK116296A HK116296A (en) 1989-05-19 1996-07-04 Amide derivatives and dermatologic preparations containing the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP12646289A JPH072698B2 (en) 1989-05-19 1989-05-19 Amide derivative and external preparation for skin containing the same

Publications (2)

Publication Number Publication Date
JPH02306952A JPH02306952A (en) 1990-12-20
JPH072698B2 true JPH072698B2 (en) 1995-01-18

Family

ID=14935817

Family Applications (1)

Application Number Title Priority Date Filing Date
JP12646289A Expired - Lifetime JPH072698B2 (en) 1989-05-19 1989-05-19 Amide derivative and external preparation for skin containing the same

Country Status (1)

Country Link
JP (1) JPH072698B2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5753707A (en) * 1995-09-07 1998-05-19 Kao Corporation Amide derivatives and their use in cosmetic composition

Also Published As

Publication number Publication date
JPH02306952A (en) 1990-12-20

Similar Documents

Publication Publication Date Title
US5175321A (en) Amide derivatives and dermatologic preparations containing the same
US7351716B2 (en) Dermatological preparations
JP3245748B2 (en) P-menthane derivative and cooling sensate containing the same
JPH0517399A (en) Ester derivative and cosmetics containing the same derivative
JP2014198708A (en) Ceramide-like function imparting agent
JPH0142934B2 (en)
JP4070357B2 (en) Skin preparation
JP2686172B2 (en) Amide derivative and external preparation for skin containing the same
JPH072698B2 (en) Amide derivative and external preparation for skin containing the same
JPH0676358B2 (en) Amide derivative and external preparation for skin containing the same
US5221757A (en) Amide derivatives and dermatologic preparations containing the same
JP4112741B2 (en) Moisturizer
JP2551471B2 (en) Glyceryl ether derivative and skin external preparation containing the same
JP3073813B2 (en) Cosmetics
US5801258A (en) Amide derivatives and dermatologic preparations containing the same
JPH05255186A (en) 3-substituted-p-menthane derivative and cold-sensation agent containing the same derivative
JPH0692293B2 (en) External skin preparation
JPH078844B2 (en) Amide derivative and external preparation for skin containing the same
JPH02306949A (en) Amide derivative and external preparation for skin containing the same
JP3769056B2 (en) Amine derivative and skin external preparation containing the same
JP3271828B2 (en) Water-in-oil emulsion cosmetics
JPH0565485B2 (en)
JP3788633B2 (en) Phosphoric acid triester and cosmetics and external preparations containing the same
JP2704759B2 (en) Glyceryl ether derivative and external preparation for skin containing the same
JP4220625B2 (en) External preparation composition

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (prs date is renewal date of database)

Year of fee payment: 14

Free format text: PAYMENT UNTIL: 20090118

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090118

Year of fee payment: 14

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100118

Year of fee payment: 15

EXPY Cancellation because of completion of term
FPAY Renewal fee payment (prs date is renewal date of database)

Year of fee payment: 15

Free format text: PAYMENT UNTIL: 20100118